For instance, in HNSCC, PD-L1 is predominantly expressed in antigen-presenting cells (APCs) and tumour cells, whereas PD-L2 is predominantly present in a broad range of immune cells, including macrophages and myeloid-derived mast cells. The gene discussed is PDCD1LG2; the disease is head and neck squamous cell carcinoma.